In this regard, in a Kras-driven non-small cell lung cancer (NSCLC) mouse model with a concurrent deletion of Atg7 to inhibit autophagy in the tumors, the authors found a decrease in tumor growth with accumulation of defective mitochondria. The gene discussed is KRAS; the disease is neoplasm.